Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
Clinical trial NCT03768570 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03768570
- Sponsor
- Canadian Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-25
- Primary completion
- 2026-10-31
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.